FABP5 and colorectal carcinoma: Mechanistic studies have shown that FABP5 expression is upregulated in metastatic CRC cells by continuously promoting DNA demethylation and activation of the NF-κB pathway, which in turn regulates NF-κB activity through IL-8 production [101].